Načítá se...
Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease
Despite the continued development of cystic fibrosis transmembrane conductance regulator (CFTR) modulator drugs for the treatment of cystic fibrosis (CF), the need for mutation agnostic treatments remains. In a sub-group of CF individuals with mutations that may not respond to modulators, such as th...
Uloženo v:
| Vydáno v: | Genes (Basel) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6471883/ https://ncbi.nlm.nih.gov/pubmed/30875857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes10030218 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|